Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Cross-sectional Study on Prevalence of Primary Aldosteronism in Resistant Hypertension and Association With Cardiometabolic Complications

NCT04213963 is registered in ClinicalTrials.gov with University of Turin, Italy as lead sponsor.

NCT NCT04213963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04213963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Cross-sectional Study on Prevalence of Primary Aldosteronism in Resistant Hypertension and Association With Cardiometabolic Complications
Lead sponsor
University of Turin, Italy
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2011
Completion date
October 31, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic ectasia, atrial fibrillation, hypertensive end-organ damage, primary aldosteronism, refractory hypertension, resistant hypertension